Big Win: Mallinckrodt’s $925M Therakos Sale Cuts Debt
Discover how Mallinckrodt's successful $925M sale of Therakos to CVC Capital Partners significantly reduces debt by over 50%.
Power Play: Quantum Capital’s $3B Bold Move in U.S. Energy Market
Quantum Capital's acquisition of Cogentrix Energy for $3B marks a strategic move to capitalize on soaring electricity demand in key U.S. markets.
Power Up: CELFX’s $1.175 Billion Credit Surge for Thriving Expansion
CELFX secures $1.175 billion credit facility to fuel growth and expand assets. Discover how this boost enhances their investment strategy.
Massive $12M Boost: Eupraxia’s Funding Fuels Breakthrough Drug Research
Eupraxia Pharmaceuticals has secured a $12M loan to advance drug innovations and ensure financial stability through 2025. Learn how this funding fuels their breakthrough treatments.